Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment

LONDON--()-- 

Ap19

FORM 8.3 Amendment to Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 09 December 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

3,051,388

2.37%

690,199

0.54%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

365,705

0.28%

739,005

0.57%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

TOTAL:

 

 

 

 

3,417,093

2.65%

1,429,204

1.11%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase

1

207.7800 USD

Purchase

1

207.8700 USD

Purchase

1

208.8800 USD

Purchase

1

209.1000 USD

Purchase

3

208.4533 USD

Purchase

4

208.1950 USD

Purchase

5

207.4480 USD

Purchase

6

207.8758 USD

Purchase

7

208.0875 USD

Purchase

9

207.7061 USD

Purchase

9

206.8255 USD

Purchase

12

208.0616 USD

Purchase

13

208.4846 USD

Purchase

13

207.9638 USD

Purchase

14

208.0014 USD

Purchase

20

207.0600 USD

Purchase

70

206.7314 USD

Purchase

100

207.0900 USD

Purchase

100

208.8700 USD

Purchase

100

208.6500 USD

Purchase

119

206.7800 USD

Purchase

192

208.8300 USD

Purchase

230

206.7600 USD

Purchase

236

208.1547 USD

Purchase

283

206.8366 USD

Purchase

492

207.2058 USD

Purchase

494

208.2250 USD

Purchase

860

206.9623 USD

Purchase

3,133

207.5756 USD

Purchase

3,844

208.9084 USD

Purchase

3,950

207.0393 USD

Purchase

4,423

207.5700 USD

Purchase

5,517

207.7112 USD

Purchase

5,642

207.6126 USD

Purchase

9,021

208.1156 USD

Purchase

9,394

208.0043 USD

Purchase

9,490

208.0792 USD

Sale

2

208.6400 USD

Sale

200

208.0750 USD

Sale

200

210.1200 USD

Sale

224

207.9007 USD

Sale

463

208.2467 USD

Sale

593

209.4893 USD

Sale

686

207.1322 USD

Sale

1,644

207.5657 USD

Sale

2,043

207.8645 USD

Sale

2,727

208.8277 USD

Sale

2,789

207.5700 USD

Sale

3,220

207.5884 USD

Sale

5,517

207.7112 USD

Sale

7,845

208.0546 USD

Sale

8,558

208.1085 USD

Sale

9,140

208.1609 USD

Sale

11,766

207.3012 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure:

16 Dec 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

 

Category Code: RET
Sequence Number: 724766
Time of Receipt (offset from UTC): 20201216T024726+0000

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC